Erbulin Mesylate - Anti-cancer
Drug Name:
Erbulin Mesylate - Anti-cancer
List Of Brands:
Indication Type Description:
Indication:
Proprietary Name- Erbulin Mesylate
Established Name - Erbulin Mesylate
Applicant- Easi INC.
Indication-
Indicated for treatment of patients with metastatic breast cancer who have
previously received at least two chemotherapeutic regimen
Approved by FDA on 15-11-2010 (Ref- FDA approved List- 2010)
Dosages/ Overdosage Etc:
Indication-
Indicated for treatment of patients with metastatic breast cancer who have
previously received at least two chemotherapeutic regimen